RxDoctor Payments Data

Nanditha Krishnamsetty, MD

Child & Adolescent Psychiatry · Old Bridge, NJNPI 1174582746

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 37.6% of the total. Among child & adolescent psychiatry clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,603in general payments, 2019–2025

Across 328 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$697
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$645
  • Lundbeck LLC$298
  • Johnson & Johnson$252
  • Takeda Pharmaceuticals U.S.A., Inc.$230
  • plus $751 from 11 others

What the payments were for

  • Food & beverage$4,39295%
  • Education$2115%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,603 in reported general payments places this provider in the 90th percentile of 137 child & adolescent psychiatry providers in New Jersey.

See all child & adolescent psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$11,426
Medicare patients
39
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Quetiapine Fumarate94$1,669
Bupropion XlBupropion Hcl32$1,259
Aripiprazole22$1,020
Duloxetine Hcl71$1,020
Venlafaxine Hcl ErVenlafaxine Hcl55$857
Escitalopram Oxalate81$657
Buspirone Hcl46$610
Mirtazapine78$584
Bupropion Hcl SrBupropion Hcl33$577
Olanzapine20$391
Trazodone Hcl64$385
Clonazepam77$347
Desvenlafaxine Succinate ErDesvenlafaxine Succinate15$337
Topiramate18$177
Gabapentin33$175

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Old Bridge

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →